Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As(2)O(3)), conventional chemotherapy, and autologous peripheral blood stem cell transplantation. We attempted to use both tamibarote...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojima, Minoru, Ogiya, Daisuke, Ichiki, Akifumi, Hara, Ryujiro, Amaki, Jun, Kawai, Hidetsugu, Numata, Hiroki, Sato, Ai, Miyamoto, Mitsuki, Suzuki, Rikio, Machida, Shinichiro, Matsushita, Hiromichi, Ogawa, Yoshiaki, Kawada, Hiroshi, Ando, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840419/
https://www.ncbi.nlm.nih.gov/pubmed/27144119
http://dx.doi.org/10.1016/j.lrr.2016.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840419/
https://www.ncbi.nlm.nih.gov/pubmed/27144119
http://dx.doi.org/10.1016/j.lrr.2016.01.001

Ejemplares similares